Drugs that contain Nepafenac

1. Drug name - ILEVRO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7947295 NOVARTIS Ophthalmic compositions containing a synergistic combination of two polymers Jun, 2024

(1 year, 8 months from now)

US9662398 NOVARTIS Carboxylvinyl polymer-containing nanoparticle suspensions Dec, 2030

(8 years from now)

US8921337 NOVARTIS Carboxyvinyl polymer-containing nanoparticle suspensions Mar, 2032

(9 years from now)

Treatment: NA

Dosage: SUSPENSION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.3% SUSPENSION/DROPS;OPHTHALMIC Prescription

2. Drug name - NEVANAC

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8071648 NOVARTIS Topical nepafenac formulations Dec, 2025

(3 years from now)

US8324281 NOVARTIS Topical nepafenac formulations Dec, 2025

(3 years from now)

US7834059 NOVARTIS Topical nepafenac formulations Jan, 2027

(4 years from now)

Treatment: Method of treating ocular inflammation

Dosage: SUSPENSION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.1% SUSPENSION/DROPS;OPHTHALMIC Prescription

availability in other generic markets.

Click on the highlighted region to filter.